A Study of MRG007 (ARR-217) in Patients With Advanced Solid Tumors

ClinicalTrials.gov ID: NCT07066657

Public ClinicalTrials.gov record NCT07066657. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

View official ClinicalTrials.gov record → Back to search

ClinicalTrials.gov public records Last synced Jul 21, 2026, 4:43 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

An Open-Label, Multi-Center, Dose Escalation, Confirmation, and Expansion Phase I Clinical Study to Evaluate the Safety, Tolerability, Efficacy, and Pharmacokinetics of MRG007 (ARR-217) in Participants With Unresectable Locally Advanced or Metastatic Solid Tumors

Study identification

NCT ID: NCT07066657
Recruitment status: Recruiting
Study type: Interventional
Phase: Phase 1
Lead sponsor: ArriVent BioPharma, Inc.; Industry
Enrollment: 405 participants

Conditions and interventions

Conditions

Interventions

MRG007 Drug

Drug

Eligibility (public fields only)

Age range: 18 Years and older
Sex: All
Healthy volunteers: Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date: Jul 24, 2025
Primary completion: Apr 30, 2029
Completion: Nov 30, 2030
Last update posted: Jun 3, 2026

2025 – 2030

United States locations

U.S. sites: 10
U.S. states: 7
U.S. cities: 10

Facility	City	State	ZIP	Site status
ULCA	Los Angeles	California	90095	Recruiting
UCSF	San Francisco	California	94158	Not yet recruiting
University of Colorado	Aurora	Colorado	80010	Recruiting
Sarah Cannon Research Institute	Denver	Colorado	80218	Recruiting
Sarah Cannon Research Institute	Sarasota	Florida	34232	Recruiting
Sarah Cannon Research Institute	Nashville	Tennessee	37203	Recruiting
MD Anderson Cancer Center	Houston	Texas	77030	Recruiting
NEXT Dallas	Irving	Texas	75039	Recruiting
NEXT Virginia	Fairfax	Virginia	22031	Recruiting
Fred Hutchinson Cancer Center	Seattle	Washington	98109	Recruiting

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 10 non-U.S. sites.

About this trial record page

What this page shows: Public field values for ClinicalTrials.gov record NCT07066657, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do: No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from: Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh: Last update posted Jun 3, 2026 · Synced Jul 21, 2026

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT07066657 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →